Biomedical applications of chitosan nanocarriers: Design strategies and translational challenges

This is the authors' abstract. We don't add key points for this paper.

Chitosan, a natural biopolymer derived from chitin, has gained significant attention as a versatile material for nanocarrier development due to its biocompatibility, biodegradability, and tunable physicochemical properties. This review highlights the design, challenges, and biomedical applications of chitosan-based nanocarriers, emphasizing their role in advanced drug delivery, diagnostics, and regenerative medicine. Various nanostructures, including nanoparticles, nanogels, and nanofibers, can be fabricated using techniques such as ionic gelation, emulsion-based synthesis, nanoprecipitation, and electrospinning to meet specific therapeutic needs. These systems demonstrate enhanced mucoadhesion, targeted delivery, and the ability to cross biological barriers like the blood–brain barrier, enabling efficient transport of chemotherapeutics, nucleic acids, and vaccines through noninvasive routes. In addition, chitosan exhibits intrinsic antimicrobial properties, while its anti-inflammatory and antioxidant effects can be further improved through chemical modification or combination with bioactive agents, expanding its use in wound healing and tissue engineering. However, challenges such as poor solubility at physiological pH, environmental sensitivity, scalability limitations, and regulatory hurdles restrict clinical translation. Approaches including chemical modification, crosslinking, and optimized storage and sterilization have shown promise in enhancing stability. This review integrates design strategies with translational and regulatory considerations, offering a comprehensive and forward-looking perspective.